Overexpression of c-Myc triggers p62 aggregation-mediated mitochondrial mitophagy in cabozantinib resistance of hepatocellular carcinoma
Abstract Resistance to tyrosine kinase inhibitors (TKIs) poses a significant challenge in the treatment of hepatocellular carcinoma (HCC). Although dysregulation of mitochondrial dynamics has been implicated in the aggressive behaviors of various tumors, the specific role and underlying mechanisms b...
Saved in:
| Main Authors: | Kaibo Yang, Xing Zhang, Kun Yang, Sinan Liu, Jingyao Zhang, Yunong Fu, Tong Liu, Kunjin Wu, Jing Li, Chang Liu, Qichao Huang, Kai Qu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01263-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world efficacy of cabozantinib alone or in combination with ICIs in heavily pretreated hepatocellular carcinoma: potential role of AXL and MET expression
by: Kuan-Chang Lai, et al.
Published: (2025-07-01) -
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging
by: Gilberto S. Almeida, et al.
Published: (2025-07-01) -
Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology
by: Yingying Duan, et al.
Published: (2025-07-01) -
A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers
by: Guilherme Harada, MD, et al.
Published: (2025-08-01) -
Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular CarcinomaSummary
by: Ting-Chi Rebecca Wan, et al.
Published: (2025-01-01)